These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31009940)

  • 1. Advising Patients on How to Achieve Long-Term Weight Loss.
    Katzel LI; Sorkin JD
    Ann Intern Med; 2019 May; 170(10):724-725. PubMed ID: 31009940
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-Term Weight Loss With Metformin or Lifestyle Intervention.
    Ann Intern Med; 2019 May; 170(10):. PubMed ID: 31009938
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-Term Weight Loss With Metformin or Lifestyle Intervention in the Diabetes Prevention Program Outcomes Study.
    Apolzan JW; Venditti EM; Edelstein SL; Knowler WC; Dabelea D; Boyko EJ; Pi-Sunyer X; Kalyani RR; Franks PW; Srikanthan P; Gadde KM;
    Ann Intern Med; 2019 May; 170(10):682-690. PubMed ID: 31009939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity medications and the treatment of type 2 diabetes.
    Greenway F
    Diabetes Technol Ther; 1999; 1(3):277-87. PubMed ID: 11475274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity and Diabetes.
    Aras M; Tchang BG; Pape J
    Nurs Clin North Am; 2021 Dec; 56(4):527-541. PubMed ID: 34749892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weight management in type 2 diabetes mellitus.
    Siram AT; Yanagisawa R; Skamagas M
    Mt Sinai J Med; 2010; 77(5):533-48. PubMed ID: 20960555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporating practical lifestyle management for obesity.
    Bestermann WH
    J Fam Pract; 2010 May; 59(5 Suppl):S3-8. PubMed ID: 20544055
    [No Abstract]   [Full Text] [Related]  

  • 8. Metformin-induced weight loss in patients with or without type 2 diabetes/prediabetes: A retrospective cohort study.
    Chukir T; Mandel L; Tchang BG; Al-Mulla NA; Igel LI; Kumar RB; Waitman J; Aronne LJ; Shukla AP
    Obes Res Clin Pract; 2021; 15(1):64-68. PubMed ID: 33386253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lifestyle-recommendations on weight loss in type 2 diabetes--useful, or not?].
    Admiraal WM; Holleman F; Hoekstra JB
    Ned Tijdschr Geneeskd; 2013; 157(43):A6813. PubMed ID: 24152367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes.
    Lee A; Morley JE
    Obes Res; 1998 Jan; 6(1):47-53. PubMed ID: 9526970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation at the melanocortin 4 receptor gene and response to weight-loss interventions in the diabetes prevention program.
    Pan Q; Delahanty LM; Jablonski KA; Knowler WC; Kahn SE; Florez JC; Franks PW;
    Obesity (Silver Spring); 2013 Sep; 21(9):E520-6. PubMed ID: 23512951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of the treatment with dapagliflozin and metformin compared to metformin monotherapy for weight loss in patients with class III obesity: a randomized controlled trial.
    Ferreira-Hermosillo A; Molina-Ayala MA; Molina-Guerrero D; Garrido-Mendoza AP; Ramírez-Rentería C; Mendoza-Zubieta V; Espinosa E; Mercado M
    Trials; 2020 Feb; 21(1):186. PubMed ID: 32059692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.
    ; Knowler WC; Fowler SE; Hamman RF; Christophi CA; Hoffman HJ; Brenneman AT; Brown-Friday JO; Goldberg R; Venditti E; Nathan DM
    Lancet; 2009 Nov; 374(9702):1677-86. PubMed ID: 19878986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic predictors of weight loss and weight regain after intensive lifestyle modification, metformin treatment, or standard care in the Diabetes Prevention Program.
    Delahanty LM; Pan Q; Jablonski KA; Watson KE; McCaffery JM; Shuldiner A; Kahn SE; Knowler WC; Florez JC; Franks PW;
    Diabetes Care; 2012 Feb; 35(2):363-6. PubMed ID: 22179955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight loss/maintenance as an effective tool for controlling type 2 diabetes: novel methodology to sustain weight reduction.
    Gage D
    Diabetes Metab Res Rev; 2012 Mar; 28(3):214-8. PubMed ID: 22215481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of metformin on weight loss: potential mechanisms.
    Malin SK; Kashyap SR
    Curr Opin Endocrinol Diabetes Obes; 2014 Oct; 21(5):323-9. PubMed ID: 25105996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term effect of polyethylene glycol loxenatide on weight loss in overweight or obese patients with type 2 diabetes: An open-label, parallel-arm, randomized, metformin-controlled trial.
    Cai H; Chen Q; Duan Y; Zhao Y; Zhang X
    Front Endocrinol (Lausanne); 2023; 14():1106868. PubMed ID: 36777344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin: Mechanisms in Human Obesity and Weight Loss.
    Yerevanian A; Soukas AA
    Curr Obes Rep; 2019 Jun; 8(2):156-164. PubMed ID: 30874963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic options for the prevention of type 2 diabetes mellitus in the metabolic syndrome.
    Lukacova-Zib I; Gopalakrishnan G
    Mt Sinai J Med; 2010; 77(5):524-32. PubMed ID: 20960554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and cancer: mechanistic insights from transdisciplinary studies.
    Allott EH; Hursting SD
    Endocr Relat Cancer; 2015 Dec; 22(6):R365-86. PubMed ID: 26373570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.